Health ❯ Pharmaceuticals ❯ Drug Regulation

FDA

Peptides Compounded Drugs Compounding Pharmacies Leadership Changes Enforcement Orders Carcinogens Tirzepatide Peptide Drugs Advisory Committees Peptide Therapies

FDA Asks Drugmakers for More Data on Testosterone Use in Menopausal Women

This could open a pathway to female-specific approvals if trials resolve unanswered risks to heart and breast health.

FDA Reviews Influencer-Driven Peptides as Panel Weighs Compounding Access

FDA Scientists Say Evidence Lacks for Allowing Seven Popular Peptides in Compounding

ImmunityBio Investors Face May 26 Lead-Plaintiff Deadline in Securities Suit Tied to FDA Anktiva Rebuke

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

Wegovy Prescriptions Surge as FDA Ban Cuts Into Copycats

FDA Flags Possible License Revocation for Sarepta’s Elevidys

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research

FDA Moves to Ban Ineffective Cold Medicine Ingredient

FDA Proposes Removal of Ineffective Oral Phenylephrine from Cold Medicines

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy